DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
ELTANEXOR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ELTANEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
Q59IQJ9NTK
Molecule Type:
Small molecule
Molecular Formula:
C17H10F6N6O
Molecular Weight:
428.3
AlogP:
3.26
PSA:
99.58
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BMS-908662
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-908662
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)
1
Small molecule
Investigational
Unknown
Unknown
Acquired Immunodeficiency Syndrome
Unknown
CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)
×
Maximum Phase:
1
First Approval:
None
UNII:
HHT01ZNK31
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
2MD
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
2MD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LS-104
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Tyrosine-protein kinase JAK2 inhibitor
LS-104
×
Maximum Phase:
1
First Approval:
None
UNII:
T669M1395I
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIINDOLYLMETHANE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DIINDOLYLMETHANE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CH5132799
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CH5132799
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CIAFTALAN
1
Small molecule
Investigational
Unknown
Unknown
Mycosis Fungoides; Sezary Syndrome
Unknown
CIAFTALAN
×
Maximum Phase:
1
First Approval:
None
UNII:
V5PUF4VLGY
Molecule Type:
Small molecule
Molecular Formula:
C32H18N8
Molecular Weight:
514.55
AlogP:
6.87
PSA:
108.92
HBD:
2.0
HBA:
#RotB:
0.0
Source:
BPN-14967
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BPN-14967
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAK-960
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase PLK1 inhibitor
TAK-960
×
Maximum Phase:
1
First Approval:
None
UNII:
3831VFM1ZB
Molecule Type:
Small molecule
Molecular Formula:
C27H34F3N7O3
Molecular Weight:
561.61
AlogP:
3.55
PSA:
102.93
HBD:
2.0
HBA:
#RotB:
6.0
Source:
SNS-062
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SNS-062
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZOTIRACICLIB
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Glioblastoma; Gliosarcoma; Leukemia, Lymphocytic, Chronic, B-Cell; Rectal Neoplasms
Cyclin-dependent kinase 1 inhibitor
ZOTIRACICLIB
×
Maximum Phase:
1
First Approval:
None
UNII:
40D08182TT
Molecule Type:
Small molecule
Molecular Formula:
C23H24N4O
Molecular Weight:
372.47
AlogP:
4.66
PSA:
50.28
HBD:
1.0
HBA:
#RotB:
0.0
Source:
CT-7001
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
CT-7001
×
Maximum Phase:
1
First Approval:
None
UNII:
46D4HS9ODA
Molecule Type:
Small molecule
Molecular Formula:
C22H30N6O
Molecular Weight:
394.52
AlogP:
2.85
PSA:
86.51
HBD:
4.0
HBA:
#RotB:
7.0
Source:
MK-1064
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MK-1064
×
Maximum Phase:
1
First Approval:
None
UNII:
O812716S9E
Molecule Type:
Small molecule
Molecular Formula:
C24H20ClN5O3
Molecular Weight:
461.91
AlogP:
4.2
PSA:
99.12
HBD:
1.0
HBA:
#RotB:
7.0
Source:
PF-05241328
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-05241328
×
Maximum Phase:
1
First Approval:
None
UNII:
8RAL5N48VT
Molecule Type:
Small molecule
Molecular Formula:
C19H21ClN4O4S
Molecular Weight:
436.92
AlogP:
3.11
PSA:
103.18
HBD:
1.0
HBA:
#RotB:
6.0
Source:
PBF-509
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Parkinson Disease
Adenosine A2a receptor antagonist
PBF-509
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FK453
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Adenosine A1 receptor antagonist
FK453
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C23H25N3O2
Molecular Weight:
375.47
AlogP:
3.78
PSA:
57.84
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TENIFATECAN
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Pancreatic Neoplasms
Unknown
TENIFATECAN
×
Maximum Phase:
1
First Approval:
None
UNII:
7G0Y719Q80
Molecule Type:
Small molecule
Molecular Formula:
C55H72N2O9
Molecular Weight:
905.19
AlogP:
11.38
PSA:
143.25
HBD:
1.0
HBA:
#RotB:
19.0
Source:
FLUOROACETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FLUOROACETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
AP1JV9U41M
Molecule Type:
Small molecule
Molecular Formula:
C2H3FO2
Molecular Weight:
78.04
AlogP:
0.04
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
RALIMETINIB
1
Small molecule
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Glioblastoma; Neoplasms; Ovarian Neoplasms; Breast Neoplasms
MAP kinase p38 alpha inhibitor
RALIMETINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
73I34XW4HD
Molecule Type:
Small molecule
Molecular Formula:
C24H29FN6
Molecular Weight:
420.54
AlogP:
5.55
PSA:
85.41
HBD:
2.0
HBA:
#RotB:
3.0
Source:
VT-1598
1
Small molecule
Investigational
Unknown
Unknown
Coccidioidomycosis
Unknown
VT-1598
×
Maximum Phase:
1
First Approval:
None
UNII:
AV9K9X720D
Molecule Type:
Small molecule
Molecular Formula:
C31H20F4N6O2
Molecular Weight:
584.53
AlogP:
4.88
PSA:
109.74
HBD:
1.0
HBA:
#RotB:
8.0
Source:
ABTL-0812
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Pancreatic Neoplasms
Unknown
ABTL-0812
×
Maximum Phase:
1
First Approval:
None
UNII:
0DE74TJ7EZ
Molecule Type:
Small molecule
Molecular Formula:
C18H32O3
Molecular Weight:
296.45
AlogP:
4.86
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
14.0
Source:
AV-412
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AV-412
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NKTR-171
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel alpha subunit blocker
NKTR-171
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OLOCROLIMUS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
FK506-binding protein 1A inhibitor
OLOCROLIMUS
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELSULFAVIRINE SODIUM
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
ELSULFAVIRINE SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
HKK2U3V1DT
Molecule Type:
Small molecule
Molecular Formula:
C24H16BrCl2FN3NaO5S
Molecular Weight:
651.27
AlogP:
5.96
PSA:
125.36
HBD:
2.0
HBA:
#RotB:
8.0
Source:
GSK1482160
1
Small molecule
Investigational
Unknown
Unknown
Pain
P2X purinoceptor 7 negative allosteric modulator
GSK1482160
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OBP-801
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OBP-801
×
Maximum Phase:
1
First Approval:
None
UNII:
30Q3VS5HZ4
Molecule Type:
Small molecule
Molecular Formula:
C20H31N3O6S2
Molecular Weight:
473.62
AlogP:
0.52
PSA:
133.83
HBD:
4.0
HBA:
#RotB:
1.0
Source:
CEP-2563
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Neurotrophic tyrosine kinase receptor inhibitor
CEP-2563
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEDALINAB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cannabinoid CB2 receptor agonist
TEDALINAB
×
Maximum Phase:
1
First Approval:
None
UNII:
5R7X34Y6Q1
Molecule Type:
Small molecule
Molecular Formula:
C19H21F2N3O
Molecular Weight:
345.39
AlogP:
4.04
PSA:
46.92
HBD:
1.0
HBA:
#RotB:
2.0
Source:
S-3304
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms
Unknown
S-3304
×
Maximum Phase:
1
First Approval:
None
UNII:
BK459F050X
Molecule Type:
Small molecule
Molecular Formula:
C24H20N2O4S2
Molecular Weight:
464.57
AlogP:
3.91
PSA:
99.26
HBD:
3.0
HBA:
#RotB:
6.0
Source:
AXT914
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AXT914
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FOLIGLURAX
1
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease
Metabotropic glutamate receptor 4 positive allosteric modulator
FOLIGLURAX
×
Maximum Phase:
1
First Approval:
None
UNII:
FR50CP1D6W
Molecule Type:
Small molecule
Molecular Formula:
C23H23N3O3S
Molecular Weight:
421.52
AlogP:
4.26
PSA:
71.09
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TAK-243
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TAK-243
×
Maximum Phase:
1
First Approval:
None
UNII:
V9GGV0YCDI
Molecule Type:
Small molecule
Molecular Formula:
C19H20F3N5O5S2
Molecular Weight:
519.53
AlogP:
1.75
PSA:
152.07
HBD:
4.0
HBA:
#RotB:
7.0
Source:
CARBENDAZIM
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Unknown
CARBENDAZIM
×
Maximum Phase:
1
First Approval:
None
UNII:
H75J14AA89
Molecule Type:
Small molecule
Molecular Formula:
C9H9N3O2
Molecular Weight:
191.19
AlogP:
1.74
PSA:
67.01
HBD:
2.0
HBA:
#RotB:
1.0
Source:
1
2
…
81
82
83
84
85
86
87
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA